Molecular and Functional Neurobiology

Appeler Site Web Contacter l'entreprise

Molecular and Functional Neurobiology Molecular and Functional Neurobiology group is led by Ass. Prof. As we are a multilingual group posts on this page will be written in different languages.

6 people from 6 different nations speaking more than 7 languages and working together on discovering new roles of mitochondria in Parkinson's disease at the Luxembourg Center for Systems Biomedicine. Dr. Anne Grünewald and was established in 2016 under the auspices of the Luxembourg National Research Fund’s ATTRACT Programme.

Here, you can learn more about the main goal of the MFN group and what we strive to achieve:

The main goal of the Molecular and Functional Neurobiology group is to understand the mechanisms that underlie movement disorders, such as Parkinson’s disease (PD) or Myclonus Dystonia (M-D). We apply molecular, ‘omics’ and single-cell approaches to postmortem brain tissue and iPSC-derived neuronal cultures to decipher genetic and non-genetic origins of such diseases.
For PD, in the majority of patients, no genetic cause can be identified. We therefore explore the role of the mitochondrial genome in pathogenesis of these so-called idiopathic cases using postmortem and iPSC-derived tissue. Somatic changes affecting the integrity and replication of the mitochondrial DNA (mtDNA) in dopaminergic neurons are likely part of the disease process. Employing laser-capture microdissection, RNA-sequencing and quantitative immunofluorescence, we aim to identify the cellular pathways linked to mtDNA disintegration in idiopathic PD. Such novel pathways may be the targets for therapeutic intervention in the future.
For those cases of PD that have a genetic origin, we are targeting cellular factors that are associated with penetrance, i.e. that determine the likelihood that an individuals carrying a certain gene variant also develops the disease. These biomarkers may either serve to indicate advanced disease progression or they may, ideally, also direct us to cellular processes that can be modulated by drugs to delay the onset of PD.
Beyond PD, the Molecular and Functional Neurobiology group is also studying the cellular mechanisms underlying M-D using iPSC-derived patient neurons. This work is performed in close collaboration with Institute of Neurogenetics at the University of Lübeck (Germany).

🌍 What a year for MFN!Our team travelled near and far to learn about the latest Parkinson’s research, exchange ideas, an...
15/10/2026

🌍 What a year for MFN!

Our team travelled near and far to learn about the latest Parkinson’s research, exchange ideas, and share our work with the scientific community!

🇩🇰 Ilaria, Begoña, Remon, and Anne attended the AD/PD Conference in Copenhagen, Denmark.

🇳🇱 Maria and Vincent joined the Human Neuroanatomy Course in Maastricht, the Netherlands, to deepen their understanding of the brain.

🏴󠁧󠁢󠁳󠁣󠁴󠁿 They also travelled to Dundee, Scotland, for a conference focused on LRRK2, coming back with new knowledge and lots of ideas!

🇪🇸 Later that year, they went to Granada, Spain, for a summer school on mass spectrometry data analysis and metabolomics, where they expanded their skills and connected with fellow researchers.

🇰🇷 Most recently, Begoña, Ilaria, and Jenny returned from Seoul, South Korea, where they attended the International Congress of Parkinson’s Disease and Movement Disorders (MDS Congress).

Different destinations, one shared goal: advancing our understanding of Parkinson’s disease and bringing what we learn back to the MFN community.

Who said research is boring? 😃

Aloha from Hawaii! 🌺Maria Tziortziou and Jenny Ghelfi recently attended the MDS Conference in Hawaii, where they had the...
10/10/2025

Aloha from Hawaii! 🌺

Maria Tziortziou and Jenny Ghelfi recently attended the MDS Conference in Hawaii, where they had the opportunity to present their work during the poster session. Maria was also honored to present her research during an oral platform session.
It was an inspiring event filled with world-class research presentations, and a great opportunity to connect with fellow researchers and industry leaders.
Mahalo, Hawaii! 🌊🌴

13/11/2024

Christmas spirit has arrived 🎄 🎁

Dear all, These last few months were very exciting, and we would like to share some news with you:   In June, Gideon Agy...
09/10/2023

Dear all,
These last few months were very exciting, and we would like to share some news with you:

In June, Gideon Agyeah attended the EUROMIT Conference in Bologna. He had the opportunity to exhibit his poster at the conference entitled: Metabolic modulation of mitochondrial DNA release in cellular models of Parkin-associated Parkinson’s disease.
At the same time, Prof. Grünewald, Dr. Venegas Maldonado and Dr. Pereira visited the 6th World Parkinson Congress in Barcelona. Prof. Grünewald gave a talk about “ Mitochondria at the interface between neurodegeneration and inflammation “ and was Co-moderator in the parallel session titled “Do known causes of PD converge to a shared mechanism? ».

In July, the LCSB had the honor to welcome Federal President Frank-Walter Steinmeier and his spouse, together with HRH Grand Duke Henry and HRH Grand-Duchess Maria Teresa and Minister of Research Claude Meisch.
Our team was privileged to explain our research and the different disease models used at the institute to the visitors.
https://www.uni.lu/lcsb-fr/news/federal-president-steinmeier-and-hrh-grand-duke-henry-visit-the-lcsb/


In August, Patrycja Mulica, former PhD student of the group, published her paper entitled "Comparison of two protocols for the generation of iPSC-derived human astrocytes" in BMC.
https://biologicalproceduresonline.biomedcentral.com/articles/10.1186/s12575-023-00218-x

In September, Prof. Grünewald, Maria Tziortziou, Gideon Agyeah and Jenny Ghelfi had the possibility to attend the 2023 International Congress of Parkinson’s Disease and Movement Disorder in Copenhagen (Denmark).
Our research was on display during the poster sessions, and we appreciated the fruitful discussions with experts in the fields of movement disorders and Parkinson’s disease.

In October, we had to say goodbye to two of our visitors: Ilaria Goglia, a PhD student in neuroscience from the University of Milano-Bicocca, and Beatriz Monteiro, a Master Student from the Instituto Superior Técnico from the University of Lisbon. It was a great pleasure to host them in our group for the last six months. We wish you both the best for your future.
Card : ®Ilara Goglia

We are happy and proud to announce that Patrycja Mulica successfully defended her PhD thesis entitled : “Studying the im...
15/05/2023

We are happy and proud to announce that Patrycja Mulica successfully defended her PhD thesis entitled : “Studying the impact of A53T alpha synuclein on astrocytic functions and activation in human iPSC- derived cultures”.
Congratulations on earning your PhD, Patrycja! 🥳

Additional exciting news about Semra’s work:  Her paper “Single cell sequencing of human midbrain reveals glial activati...
11/10/2022

Additional exciting news about Semra’s work: Her paper “Single cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state” (BRAIN) was featured during the “Movement Disorder Research Highlights from 2022” session in Madrid. 🤩

https://academic.oup.com/brain/article/145/3/964/6469020

https://www.mdscongress.org/Program/Scientific-Program/Sessions/Movement-Disorder-Research-Highlights-from-2022-From-the-Bench-to-the-Bedside

https://www.movementdisorders.org/MDS.htm

We are happy to announce that another of our PhD students, Semra Smajić, successfully defended her PhD thesis ‘The role ...
10/10/2022

We are happy to announce that another of our PhD students, Semra Smajić, successfully defended her PhD thesis ‘The role of neuromelanin in dopaminergic neuron demise and inflammation in idiopathic Parkinson’s disease’. She investigated the single-cell transcriptome of Parkinson’s patient midbrain with a focus on inflammation and neuromelanin.

Congratulations to Dr. Semra Smajić 🥳

Adresse

Luxembourg

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Molecular and Functional Neurobiology publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter L'entreprise

Envoyer un message à Molecular and Functional Neurobiology:

Raccourcis

Partager